Novanta Inc experienced a notable increase in its stock price, reflecting positive investor sentiment.
Novanta Inc (NASDAQ:NOVT) went up yesterday by 2.65%, closing at CA$145.03. This rise can be attributed to renewed interest in robotics and automation sectors, particularly as investors anticipate significant growth driven by advancements in artificial intelligence.
Advertisement
Novanta Inc
NOVT.US
NOVT.US
Novanta Inc
WealthAwesomeMarket cap
$5.34B
P/E
89.4x
52W high
$176.38
52W low
$98.27
1W change
-3.70%
Beta
1.73
Analyst Price Targets
Based on 3 analysts covering NOVT · as of Oct 5, 2026
Wall Street analysts forecast NOVT stock price to rise 34.1% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
C$194.50
+34.1% Upside
Current Price
C$145.03
Last close
Analyst Breakdown (3 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NOVT's historical volatility
30-Day Vol
42.1%
Annualized
90-Day Vol
48.4%
Annualized
Trend (90d)
-10.5%
Annualized drift
90d Mean
C$139.68
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$143.22 | C$123.85 – C$165.63 |
| 60 trading days | C$141.44 | C$115.16 – C$173.72 |
| 90 trading days | C$139.68 | C$108.59 – C$179.67 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are increasingly optimistic about Novanta's role in the robotics and medical technology markets, especially with its balanced revenue streams and potential for future growth.
2.65% Increase
Novanta's stock price increase reflects strong market confidence and the company's strategic positioning within the growing robotics and medical technology sectors.
Bull case
The company's diverse offerings in automation and medical solutions position it well to meet the rising demand for robotics and minimally invasive surgeries. This could lead to steady revenue growth and improved profit margins.
Bear case
Despite its positive trajectory, Novanta faces challenges like high valuation ratios and market volatility that could affect its future performance, especially if the overall economic situation worsens.
Advertisement
Market Position and Growth Potential
Novanta has established itself as a key player in the robotics and medical technology fields, generating approximately US$523 million from Automation Enabling Technologies and US$506 million from Medical Solutions. This balanced revenue mix is crucial as the company navigates the growing demand for automation and minimally invasive surgical solutions.
Investor Sentiment and Future Outlook
The recent stock price increase reflects positive investor sentiment, fueled by projections of a 20.5% revenue growth over the next year. Analysts are optimistic about Novanta's ability to leverage its technological advancements and market position to deliver sustained growth, making it a compelling option for investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
